Effectiveness and Tolerability of 12-Month Brivaracetam in the Real World: EXPERIENCE, an International Pooled Analysis of Individual Patient Records
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effectiveness and Tolerability of 12-Month Brivaracetam in the Real World: EXPERIENCE, an International Pooled Analysis of Individual Patient Records
Authors
Keywords
-
Journal
CNS DRUGS
Volume 37, Issue 9, Pages 819-835
Publisher
Springer Science and Business Media LLC
Online
2023-09-09
DOI
10.1007/s40263-023-01033-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sustained seizure freedom with adjunctive brivaracetam in patients with focal onset seizures
- (2022) Simona Lattanzi et al. EPILEPSIA
- Retention, efficacy, tolerability, and quality of life during long-term adjunctive brivaracetam treatment by number of lifetime antiseizure medications: A post hoc analysis of phase 3 trials in adults with focal seizures
- (2022) Christian Brandt et al. EPILEPSY & BEHAVIOR
- Behavioral adverse events with brivaracetam, levetiracetam, perampanel, and topiramate: A systematic review
- (2021) Bernhard J. Steinhoff et al. EPILEPSY & BEHAVIOR
- Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST)
- (2021) Simona Lattanzi et al. CNS DRUGS
- Long‐term efficacy, tolerability, and retention of brivaracetam in epilepsy treatment: A longitudinal multicenter study with up to 5 years of follow‐up
- (2021) Adam Strzelczyk et al. EPILEPSIA
- Long-term efficacy and tolerability of adjunctive brivaracetam in adults with focal to bilateral tonic-clonic (secondary generalized) seizures: Post hoc pooled analysis
- (2021) Brian D. Moseley et al. EPILEPSY RESEARCH
- Efficacy of Brivaracetam in children with epilepsy
- (2021) Fernando Ferragut Ferretjans et al. EPILEPSY RESEARCH
- Brivaracetam efficacy and tolerability in clinical practice: A UK-based retrospective multicenter service evaluation
- (2020) J. Adewusi et al. EPILEPSY & BEHAVIOR
- Time course of drug-related treatment-emergent adverse side effects of brivaracetam
- (2020) Kimford J. Meador et al. EPILEPSY & BEHAVIOR
- Dysautonomia is associated with structural and functional alterations in Parkinson disease
- (2019) Seok Jong Chung et al. NEUROLOGY
- Efficacy, retention, and safety of brivaracetam in adult patients with genetic generalized epilepsy
- (2019) Elena Fonseca et al. EPILEPSY & BEHAVIOR
- Use of brivaracetam in genetic generalized epilepsies and for acute, intravenous treatment of absence status epilepticus
- (2018) Adam Strzelczyk et al. EPILEPSIA
- Brivaracetam in the Treatment of Patients with Epilepsy—First Clinical Experiences
- (2018) Felix Zahnert et al. Frontiers in Neurology
- BRIVA-LIFE-A multicenter retrospective study of the long-term use of brivaracetam in clinical practice
- (2018) Vicente Villanueva et al. ACTA NEUROLOGICA SCANDINAVICA
- Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology
- (2017) Robert S. Fisher et al. EPILEPSIA
- Postmarketing experience with brivaracetam in the treatment of epilepsies: A multicenter cohort study from Germany
- (2017) Isabel Steinig et al. EPILEPSIA
- Efficacy and tolerability of adjunctive brivaracetam in patients with prior antiepileptic drug exposure: A post-hoc study
- (2017) Ali A. Asadi-Pooya et al. EPILEPSY RESEARCH
- Real-life experience with brivaracetam in 101 patients with difficult-to-treat epilepsy—A monocenter survey
- (2017) Bernhard J. Steinhoff et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Evidence for a differential interaction of brivaracetam and levetiracetam with the synaptic vesicle 2A protein
- (2016) Martyn D. Wood et al. EPILEPSIA
- Efficacy, safety, and tolerability of adjunctive brivaracetam for secondarily generalized tonic-clonic seizures: Pooled results from three Phase III studies
- (2016) Brian D. Moseley et al. EPILEPSY RESEARCH
- A randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial-onset seizures
- (2015) Pavel Klein et al. EPILEPSIA
- An open-label, prospective, exploratory study of patients with epilepsy switching from levetiracetam to brivaracetam
- (2015) Stephen L. Yates et al. EPILEPSY & BEHAVIOR
- Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: A phase III randomized, double-blind, placebo-controlled trial
- (2013) Victor Biton et al. EPILEPSIA
- Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: Results from a double-blind, randomized, placebo-controlled trial
- (2013) Philippe Ryvlin et al. EPILEPSIA
- Assessing the Comparative Effectiveness of Newly Marketed Medications: Methodological Challenges and Implications for Drug Development
- (2011) S Schneeweiss et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search